Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BERLIN CHEMIE AG [DE]”

18 pharma patents match "BERLIN CHEMIE AG [DE]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 18
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 18 pharmaceutical patents matching "BERLIN CHEMIE AG [DE]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

18 results for “BERLIN CHEMIE AG [DE]” · 30,257 patents in full index Clear search

  1. WO 2024252263

    COMPOSITIONS SOLIDES DE DICHLORHYDRATE D'ÉLACESTRANT, LEURS PROCÉDÉS DE FABRICATION ET MÉTHODES DE TRAITEMENT LES UTILISANT

    BERLIN CHEMIE AG [DE] · Granted Dec 12, 2024 · Expires Dec 7, 2044

    granted
  2. WO 2024023766

    POLYTHÉRAPIE À BASE D'INHIBITEUR DE P13K

    BERLIN CHEMIE AG [DE] · Granted Feb 1, 2024 · Expires Jan 27, 2044

    granted
  3. WO 2022029639

    FORMULATIONS PHARMACEUTIQUES AMÉLIORÉES COMPRENANT DES INHIBITEURS DE PI3K

    BERLIN CHEMIE AG [DE] · Granted Feb 10, 2022 · Expires Feb 5, 2042

    granted
  4. US 2021015826

    ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY

    BERLIN CHEMIE AG [DE] · Granted Jan 21, 2021 · Expires Jan 16, 2041

    granted
  5. US 2020040086

    PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY

    BERLIN CHEMIE AG [DE] · Granted Feb 6, 2020 · Expires Feb 1, 2040

    granted
  6. CA 3102476

    ASSOCIATIONS PHARMACEUTIQUES

    BERLIN CHEMIE AG [DE] · Granted Dec 19, 2019 · Expires Dec 14, 2039

    granted
  7. EP 3576795

    ORALES SCHILDDRÜSENTHERAPEUTIKUM

    BERLIN CHEMIE AG [DE] · Granted Dec 11, 2019 · Expires Dec 6, 2039

    granted
  8. WO 2019197609

    ANTICORPS DIRIGÉS CONTRE BST1 POUR PRÉVENIR OU TRAITER LE SYNDROME MYÉLODYSPLASIQUE

    BERLIN CHEMIE AG [DE] · Granted Oct 17, 2019 · Expires Oct 12, 2039

    granted
  9. DE 102017122807

    Orales Schilddrüsentherapeutikum

    BERLIN CHEMIE AG [DE] · Granted Apr 4, 2019 · Expires Mar 30, 2039

    granted
  10. CA 3070264

    ASSOCIATIONS PHARMACEUTIQUES COMPRENANT UN ANTICORPS ANTI-BST-1 ET UN ANALOGUE DE CYTIDINE

    BERLIN CHEMIE AG [DE] · Granted Jan 24, 2019 · Expires Jan 19, 2039

    granted
  11. EP 2882753

    VERFAHREN ZUR HERSTELLUNG VON PEMETREXED UND EINEM LYSINSALZ DAVON

    BERLIN CHEMIE AG [DE] · Granted Jun 17, 2015 · Expires Jun 12, 2035

    granted
  12. PH 12013502690

    ANTIBODIES TO ADP-RIBOSYL CYCLASE 2

    BERLIN CHEMIE AG [DE] · Granted Feb 17, 2014 · Expires Feb 12, 2034

    granted
  13. WO 2007104583

    COMPRIMÉ SÉCABLE AVEC PRÉCISION

    BERLIN CHEMIE AG [DE] · Granted Sep 20, 2007 · Expires Sep 15, 2027

    granted
  14. DE 102005046769

    Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)

    BERLIN CHEMIE AG [DE] · Granted Apr 5, 2007 · Expires Mar 31, 2027

    granted
  15. EP 1613300

    PHOTOSTABILISIERTE TOPISCHE FORMULIERUNGEN VON KETOPROFEN MIT ZWEI UV-FILTERN

    BERLIN CHEMIE AG [DE] · Granted Jan 11, 2006 · Expires Jan 6, 2026

    expired
  16. EP 1488787

    Topisch anzuwendende stabilisierte Arzneimittel enthaltend Ketoprofen

    BERLIN CHEMIE AG [DE] · Granted Dec 22, 2004 · Expires Dec 17, 2024

    expired
  17. WO 03007994

    SCHILDDRÜSENTHERAPEUTIKA

    BERLIN CHEMIE AG [DE] · Granted Jan 30, 2003 · Expires Jan 25, 2023

    expired
  18. CA 2434743

    PREPARATIONS TOPIQUES DE BRIVUDINE STABILISEES

    BERLIN CHEMIE AG [DE] · Granted Jul 25, 2002 · Expires Jul 20, 2022

    expired